mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) affects more than half a million people worldwide and is the third most common cause of cancer deaths. Because mammalian target of rapamycin (mTOR) signaling is up-regulated in 50% of HCCs, we compared the effects of the U.S. Food and Drug Administration–approved mTOR-...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Thomas, Hala Elnakat, Mercer, Carol A., Carnevalli, Larissa S., Park, Jongsun, Andersen, Jesper B., Conner, Elizabeth A., Tanaka, Kazuhiro, Matsutani, Tomoo, Iwanami, Akio, Aronow, Bruce J., Manway, Liu, Maira, S. Michel, Thorgeirsson, Snorri S., Mischel, Paul S., Thomas, George, Kozma, Sara C.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703151/
https://ncbi.nlm.nih.gov/pubmed/22539746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003923
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires